Northwestern Mutual Wealth Management Co. Purchases 129 Shares of Teleflex Incorporated $TFX

Northwestern Mutual Wealth Management Co. boosted its position in Teleflex Incorporated (NYSE:TFX) by 30.2% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 556 shares of the medical technology company’s stock after purchasing an additional 129 shares during the quarter. Northwestern Mutual Wealth Management Co.’s holdings in Teleflex were worth $77,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in TFX. T. Rowe Price Investment Management Inc. raised its holdings in Teleflex by 0.7% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 6,216,763 shares of the medical technology company’s stock valued at $859,095,000 after acquiring an additional 43,642 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in Teleflex by 69.5% in the 1st quarter. Dimensional Fund Advisors LP now owns 867,864 shares of the medical technology company’s stock valued at $119,927,000 after acquiring an additional 355,720 shares in the last quarter. Diamond Hill Capital Management Inc. raised its holdings in Teleflex by 122.8% in the 1st quarter. Diamond Hill Capital Management Inc. now owns 584,586 shares of the medical technology company’s stock valued at $80,784,000 after acquiring an additional 322,222 shares in the last quarter. TD Asset Management Inc raised its holdings in Teleflex by 0.7% in the 1st quarter. TD Asset Management Inc now owns 490,000 shares of the medical technology company’s stock valued at $67,713,000 after acquiring an additional 3,310 shares in the last quarter. Finally, Deutsche Bank AG raised its holdings in Teleflex by 62.5% in the 4th quarter. Deutsche Bank AG now owns 407,129 shares of the medical technology company’s stock valued at $72,461,000 after acquiring an additional 156,524 shares in the last quarter. 95.62% of the stock is currently owned by institutional investors.

Insider Transactions at Teleflex

In related news, Director Gretchen R. Haggerty purchased 500 shares of Teleflex stock in a transaction on Wednesday, August 6th. The shares were purchased at an average price of $114.75 per share, for a total transaction of $57,375.00. Following the transaction, the director owned 6,305 shares of the company’s stock, valued at approximately $723,498.75. This represents a 8.61% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Jaewon Ryu purchased 1,500 shares of Teleflex stock in a transaction on Tuesday, August 5th. The stock was bought at an average price of $115.00 per share, for a total transaction of $172,500.00. Following the transaction, the director directly owned 3,727 shares in the company, valued at approximately $428,605. The trade was a 67.36% increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders have purchased 5,500 shares of company stock worth $633,590. 1.40% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

TFX has been the subject of several analyst reports. Wall Street Zen raised Teleflex from a “buy” rating to a “strong-buy” rating in a report on Sunday. Mizuho lifted their price objective on Teleflex from $130.00 to $135.00 and gave the company a “neutral” rating in a report on Friday, August 1st. Wells Fargo & Company dropped their price objective on Teleflex from $137.00 to $131.00 and set an “equal weight” rating for the company in a report on Friday, August 1st. Finally, Royal Bank Of Canada boosted their price target on Teleflex from $130.00 to $135.00 and gave the stock a “sector perform” rating in a report on Friday, August 1st. One equities research analyst has rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Teleflex presently has a consensus rating of “Hold” and a consensus target price of $141.57.

Teleflex Price Performance

Teleflex stock opened at $130.62 on Friday. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.44 and a current ratio of 2.41. Teleflex Incorporated has a 52 week low of $108.90 and a 52 week high of $249.90. The stock has a market capitalization of $5.77 billion, a P/E ratio of 30.73, a price-to-earnings-growth ratio of 1.82 and a beta of 1.08. The stock has a fifty day moving average of $119.91 and a 200-day moving average of $127.67.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, July 31st. The medical technology company reported $3.73 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.36 by $0.37. Teleflex had a return on equity of 15.08% and a net margin of 6.31%.The business had revenue of $780.90 million during the quarter, compared to analysts’ expectations of $771.53 million. During the same quarter in the prior year, the firm earned $3.42 EPS. The business’s revenue for the quarter was up 4.2% compared to the same quarter last year. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. On average, sell-side analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, September 15th. Shareholders of record on Friday, August 15th will be given a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date is Friday, August 15th. Teleflex’s payout ratio is 32.00%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.